{"transactions":[{"id":1655423,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-07T16:01:13.000Z","date":"2024-02-05","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 equal monthly installments, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":18.7,"expiration_date":"2034-02-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-012167","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000095017024012167/ownership.xml","form_type":"4"}},{"id":2049820,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-20T16:32:01.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":13700,"price":1.47,"value":20139.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.45 to $1.51 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":291890,"source":{"system":"sec-edgar","filing":"0001209191-23-004278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919123004278/doc4.xml","form_type":"4"}},{"id":2056562,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-11T16:39:05.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":2170,"price":1.62,"value":3515.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.6115 to $1.621 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in\nthis footnote."}],"balance_after":305590,"source":{"system":"sec-edgar","filing":"0001209191-23-002993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919123002993/doc4.xml","form_type":"4"}},{"id":2060566,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-06T16:27:03.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth of the shares underlying this option vest on January 4, 2024 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date."}],"balance_after":187500,"derivative":{"exercise_price":1.48,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0001209191-23-002341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919123002341/doc4.xml","form_type":"4"}},{"id":2060565,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-06T16:27:03.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":5000,"price":0.95,"value":4750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":307760,"source":{"system":"sec-edgar","filing":"0001209191-23-002341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919123002341/doc4.xml","form_type":"4"}},{"id":2060564,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-06T16:27:03.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":5000,"price":1.25,"value":6250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":302760,"source":{"system":"sec-edgar","filing":"0001209191-23-002341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919123002341/doc4.xml","form_type":"4"}},{"id":2422693,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-28T16:53:14.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":138750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth of the shares underlying this option vest on January 18, 2023 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date."}],"balance_after":138750,"derivative":{"exercise_price":2.19,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":138750},"source":{"system":"sec-edgar","filing":"0001209191-22-005440","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919122005440/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-20"}},{"id":2422692,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-28T16:53:14.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":46250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock of the Issuer. The shares underlying the RSU vest in 4 equal annual installments on each of January 18, 2023, January 18, 2024, January 18, 2025 and January 18, 2026, subject to the Reporting Person's continuous service as of each such vesting date."}],"balance_after":301810,"source":{"system":"sec-edgar","filing":"0001209191-22-005440","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919122005440/doc4a.xml","form_type":"4/A","original_submission_date":"2022-01-20"}},{"id":2430740,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T19:06:02.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":131250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares underlying this option vest on January 18, 2023 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date."}],"balance_after":131250,"derivative":{"exercise_price":2.19,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":131250},"source":{"system":"sec-edgar","filing":"0001209191-22-004193","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919122004193/doc4.xml","form_type":"4"}},{"id":2430739,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-20T19:06:02.000Z","date":"2022-01-19","kind":"sale","acquired":false,"shares":9050,"price":2.13,"value":19276.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021."}],"balance_after":295260,"source":{"system":"sec-edgar","filing":"0001209191-22-004193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919122004193/doc4.xml","form_type":"4"}},{"id":2430738,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-20T19:06:02.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock of the Issuer. The shares underlying the RSU vest in 4 equal annual installments on each of January 18, 2023, January 18, 2024, January 18, 2025 and January 18, 2026, subject to the Reporting Person's continuous service as of each such vesting date."}],"balance_after":299310,"source":{"system":"sec-edgar","filing":"0001209191-22-004193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919122004193/doc4.xml","form_type":"4"}},{"id":2561042,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-23T17:17:49.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":2560,"price":6.4,"value":16384.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,998 shares acquired under the Issuer's employee stock purchase plan on June 30, 2021."}],"balance_after":255560,"source":{"system":"sec-edgar","filing":"0001209191-21-057461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919121057461/doc4.xml","form_type":"4"}},{"id":2814497,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-03T19:33:00.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 24, 2018, the reporting person was granted an option to purchase 40,000 that vests in full based on the satisfaction of certain performance criteria. The performance criteria were met on March 1, 2021, resulting in the vesting of the option full."}],"balance_after":40000,"derivative":{"exercise_price":5.04,"expiration_date":"2028-10-24","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-017360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919121017360/doc4.xml","form_type":"4"}},{"id":2902575,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-20T18:17:23.000Z","date":"2021-01-18","kind":"grant","acquired":true,"shares":209375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth of the shares underlying this option vest on January 18, 2022 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":209375,"derivative":{"exercise_price":4.01,"expiration_date":"2031-01-18","underlying":"Common Stock","underlying_shares":209375},"source":{"system":"sec-edgar","filing":"0001209191-21-004473","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919121004473/doc4.xml","form_type":"4"}},{"id":2902574,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":94546,"kind":"person","name":"Ciulla Thomas","position":1,"cik":"0001815426","reported_name":"Ciulla Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-20T18:17:23.000Z","date":"2021-01-18","kind":"grant","acquired":true,"shares":103125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock of the Issuer. The shares underlying the RSU vest in 4 equal annual installments on each of January 18, 2022, January 18, 2023, January 18, 2024 and January 18, 2025, subject to the Reporting Person's continuous service as of each such vesting date, and subject to accelerated vesting in specified circumstances."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,997 shares acquired under the Issuer's employee stock purchase plan on December 31, 2020."}],"balance_after":253122,"source":{"system":"sec-edgar","filing":"0001209191-21-004473","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815426/000120919121004473/doc4.xml","form_type":"4"}}]}